Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

UNKNOWN 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Rectal Neoplasms 4Neoplasms 4Radiation Injuries 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Hormone Receptor Positive Advanced Breast Cancer 2Brain Neoplasms 2Varicose Veins 1Syphilis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Pathologic Complete Response 1Papillomavirus Infections 1Mesothelioma, Malignant 1Lymphoid Neoplasm 1Lymphocele 1Hyperparathyroidism, Primary 1Hypercalcemia 1Head and Neck Neoplasms 1HIV Infections 1HER2-positive Breast Cancer 1Cardiovascular Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

palbociclib 1Fulvestrant 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Hormone Receptor Positive Advanced Breast Cancer × Clear all
NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Unknown
600 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT05343117 2022-04-26

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

ChineseAMS

Unknown
400 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡